Mark A. Attarian
Plus aucun poste en cours
Profil
Mark A.
Attarian served as Chief Financial Officer at Track Group, Inc. in 2016.
Prior to that, he was the Chief Financial Officer & Interim EVP at Molecular Insight Pharmaceuticals, Inc. and the Chief Financial Officer & Treasurer at Joslin Diabetes Center, Inc. Attarian received his undergraduate degree from St. Lawrence University.
Anciens postes connus de Mark A. Attarian
| Sociétés | Poste | Fin |
|---|---|---|
| TRACK GROUP, INC. | Directeur Financier/CFO | 15/11/2016 |
Molecular Insight Pharmaceuticals, Inc.
 Molecular Insight Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Molecular Insight Pharmaceuticals, Inc. engages in developing and commercializing innovative molecular imaging pharmaceuticals and targeted radiotherapeutics to diagnose and treat disease. The company was founded in 1997 and the company is headquartered in Cambridge, MA. | Directeur Financier/CFO | - |
Joslin Diabetes Center, Inc.
 Joslin Diabetes Center, Inc. Pharmaceuticals: MajorHealth Technology Joslin Diabetes Center, Inc. is a non-profit organization, which engages in the development of pharmaceuticals for diabetes. It provides adult care, pediatric care, eye care, and education programs and classes. The company was founded by Elliott P. Joslin in 1893 and is headquartered in Boston, MA. | Directeur Financier/CFO | - |
Formation de Mark A. Attarian
| St. Lawrence University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| TRACK GROUP, INC. | Electronic Technology |
| Entreprise privées | 2 |
|---|---|
Joslin Diabetes Center, Inc.
Joslin Diabetes Center, Inc. Pharmaceuticals: MajorHealth Technology Joslin Diabetes Center, Inc. is a non-profit organization, which engages in the development of pharmaceuticals for diabetes. It provides adult care, pediatric care, eye care, and education programs and classes. The company was founded by Elliott P. Joslin in 1893 and is headquartered in Boston, MA. | Health Technology |
Molecular Insight Pharmaceuticals, Inc.
Molecular Insight Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Molecular Insight Pharmaceuticals, Inc. engages in developing and commercializing innovative molecular imaging pharmaceuticals and targeted radiotherapeutics to diagnose and treat disease. The company was founded in 1997 and the company is headquartered in Cambridge, MA. | Health Services |
